Press release
Deep Brain Stimulation Devices Market by its Scientific Reviews and Key Side-Effects By Players like - Aleva Neurotherapeutics SA*, Boston Scientific Corporation, Medtronic
Deep brain stimulation (DBS) device, often described as brain pacemaker, aids in alleviating symptoms of Parkinson’s disease (PD). The device is implanted at one of the three FDA approved brain sites to block the electrical signals from these sites to the brain. The three FDA approved targeted brain sites are ventrointermedialis (VIM) nucleus of the thalamus, subthalamic nucleus (STN), and globus pallidus pars interna (GPi). DBS surgery is performed on patient’s suffering from Parkinson’s disease for at least four years, and are on medications albeit with motor complications. Though there are other surgical options such as thalamotomy and pallidotomy, deep brain stimulation is the most preferred option, as it does not involve tissue destruction and is a reversible surgical treatment.The global deep brain stimulation devices market was valued at US$ 664.4 million in 2015 and is expected to expand at a CAGR of 8.2% during the forecast period (2016 – 2024).
Request For a Sample Copy of This Research Report: www.coherentmarketinsights.com/insight/request-sample/84
Aging increases the risk of Alzheimer’s disease, Parkinson’s disease and dementia. Thus, growing geriatric population is a major factor driving demand for deep brain stimulation devices. Though drug therapies are available for treating these diseases, surgical procedures are recommended in later stages of the condition. Furthermore, deep brain stimulation devices reduce the side effects and improves patient condition by reducing incidence of tremors. Patients are inclined towards adoption of minimally invasive procedures, as these require low healing time and leave behind minimal scars. Surgeons too prefer such procedures as it significantly reduces risk element from accidental damage to surrounding tissue. This is another factor fueling demand for deep brain stimulation devices globally. However, as these devices need to be implanted in the brain, it is extremely challenging and in turn reduces acceptance of DBS devices among patients.
Market Taxonomy
This report segments the global deep brain stimulation devices market on the basis of application and geography. Applications of deep brain stimulation devices are Parkinson's disease, essential tremor, dystonia, and others. For comprehensive understanding of market dynamics, the global market has been divided into key geographical regions, namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is further segmented on the basis of major countries for a macro-level understanding of the market.
Key features of the study:
This report provides in-depth analysis of the deep brain stimulation devices and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2016 – 2024, considering 2015 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
Detailed Segmentation:
Global Deep Brain Stimulation Devices Market, By Application:
Parkinson's Disease
Essential Tremor
Dystonia
Others
Increasing demand for minimally-invasive treatment options in emerging economies to create opportunities in the respective deep brain stimulation devices market
Parkinson’s and Alzheimer disease involves long-term administration of medications, making it unaffordable to major section of the population in emerging economies in Asia, Africa, and Latin America. Advent of minimally-invasive technology has led to increase in demand for such procedures and devices for treatment of chronic disease conditions such as diabetes, stroke, Parkinson’s disease, blood clot, and Alzheimer’s disease. Deep brain stimulation devices being an effective minimally-invasive therapy for Parkinson’s patients, is projected to gain significant growth traction in emerging economies such as India, China, Brazil, Israel, and North African countries. This in-turn is expected to fuel the deep brain stimulation devices market growth.
Download The PDF Brochure: www.coherentmarketinsights.com/insight/request-pdf/84
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Mr.Shah
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deep Brain Stimulation Devices Market by its Scientific Reviews and Key Side-Effects By Players like - Aleva Neurotherapeutics SA*, Boston Scientific Corporation, Medtronic here
News-ID: 1745714 • Views: …
More Releases from Coherent Market Insights
Radiation Oncology Market Set to Witness Significant Growth by 2025-2032 | Varia …
The global radiation oncology market is estimated to be valued at USD 12.51 Bn in 2025 and is expected to reach USD 16.31 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 11.2% from 2025 to 2032.
The latest report from Coherent Market Insights examines the growth prospects of the Radiation Oncology Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends, key growth…
Medical Oxygen Cylinder Market Share, Revenue, Price, Growth Rate, and Ranking A …
The global medical oxygen cylinder market is estimated to be valued at USD 4.74 Bn in 2025 and is expected to reach USD 6.90 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.5% from 2025 to 2032.
The latest report from Coherent Market Insights examines the growth prospects of the Medical Oxygen Cylinder Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends,…
Organic Skincare Market to reach Blatant Growth in Coming years by 2032 |Shiseid …
The global organic skincare market is estimated to be valued at USD 13.56 Bn in 2025 and is expected to reach USD 24.47 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 8.8% from 2025 to 2032.
The latest report from Coherent Market Insights examines the growth prospects of the Organic Skincare Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends, key growth…
Frozen Dessert Market to Witness Massive Growth by 2032 |Nestlé, Unilever, Gen …
The Global Frozen Dessert Market is estimated to be valued at USD 128.56 Bn in 2025 and is expected to reach USD 172.62 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 4.3% from 2025 to 2032.
The latest report from Coherent Market Insights examines the growth prospects of the Frozen Dessert Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends, key growth…
More Releases for Parkinson
Key Trends Reshaping the Wolff Parkinson White Syndrome Market: Technological Ad …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Wolff Parkinson White Syndrome Market Size Growth Forecast: What to Expect by 2025?
The market for Wolff Parkinson White syndrome has registered consistent growth over the recent past. The expectation is that it will expand from $1.17 billion in 2024 to $1.22 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.5%.…
Evolving Market Trends In The Anti-Parkinson Drugs Industry: Innovative Advancem …
The Anti-Parkinson Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Anti-Parkinson Drugs Market Size During the Forecast Period?
The anti-parkinson drugs market has seen significant growth in recent years, projected to increase from $10.37 billion in 2024 to $11.08 billion in…
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market?
In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced…
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market?
In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced…
Wolff Parkinson White Syndrome Treatment Market Overview 2024-2033
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Wolff Parkinson White Syndrome Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $1.43 billion…
Anti-Parkinson Drugs Market Overview
Exhibiting robust growth, the anti-parkinson drugs market is set to escalate from $9.73 billion in 2023 to $10.43 billion in 2024, with a notable Compound Annual Growth Rate (CAGR) of 7.2%. The trajectory continues on an upward trend, with an anticipated market size of $13.36 billion by 2028, sustaining a robust CAGR of 6.4%.
Increasing Geriatric Population Driving Demand:
The burgeoning geriatric population, coupled with a surge in Parkinson's disease cases,…
